Appili Lands $2.8M in AIF Funding

Halifax-based Appili Therapeutics Inc., which is developing anti-infective drugs, said last week it will receive a $2.8 million loan from the Atlantic Innovation Fund, a research fund operated by the Atlantic Canada Opportunities Agency.
The company said the funding will allow it to take its first drug, ATI-1501, through clinical trials to be ready for market approval. Last year, Appili received